HUP0400067A2 - Dementia és neurodegeneratív betegségek kezelése közepes dózisú LHRH-antagonistával - Google Patents

Dementia és neurodegeneratív betegségek kezelése közepes dózisú LHRH-antagonistával

Info

Publication number
HUP0400067A2
HUP0400067A2 HU0400067A HUP0400067A HUP0400067A2 HU P0400067 A2 HUP0400067 A2 HU P0400067A2 HU 0400067 A HU0400067 A HU 0400067A HU P0400067 A HUP0400067 A HU P0400067A HU P0400067 A2 HUP0400067 A2 HU P0400067A2
Authority
HU
Hungary
Prior art keywords
dementia
treatment
neurodegenerative diseases
lhrh antagonists
intermediate doses
Prior art date
Application number
HU0400067A
Other languages
English (en)
Hungarian (hu)
Inventor
Jürgen Engel
Rainer Voegeli
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Publication of HUP0400067A2 publication Critical patent/HUP0400067A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
HU0400067A 2001-04-30 2002-04-27 Dementia és neurodegeneratív betegségek kezelése közepes dózisú LHRH-antagonistával HUP0400067A2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28743401P 2001-04-30 2001-04-30
PCT/EP2002/004677 WO2002102401A1 (en) 2001-04-30 2002-04-27 Treatment of dementia and neurodegenerative diseases with intermediate doses of lhrh antagonists

Publications (1)

Publication Number Publication Date
HUP0400067A2 true HUP0400067A2 (hu) 2004-04-28

Family

ID=23102886

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0400067A HUP0400067A2 (hu) 2001-04-30 2002-04-27 Dementia és neurodegeneratív betegségek kezelése közepes dózisú LHRH-antagonistával

Country Status (27)

Country Link
US (1) US7288517B2 (https=)
EP (1) EP1392348B1 (https=)
JP (1) JP2004529207A (https=)
KR (1) KR20040000446A (https=)
CN (1) CN1317030C (https=)
AT (1) ATE400287T1 (https=)
AU (1) AU2002310788B2 (https=)
BG (1) BG108339A (https=)
BR (1) BR0209290A (https=)
CA (1) CA2444876A1 (https=)
CZ (1) CZ20033167A3 (https=)
DE (1) DE60227507D1 (https=)
DK (1) DK1392348T3 (https=)
ES (1) ES2307760T3 (https=)
HU (1) HUP0400067A2 (https=)
IL (1) IL156777A0 (https=)
MX (1) MXPA03008666A (https=)
NO (1) NO20034322D0 (https=)
NZ (1) NZ544417A (https=)
PL (1) PL362319A1 (https=)
PT (1) PT1392348E (https=)
RU (1) RU2319501C2 (https=)
SI (1) SI1392348T1 (https=)
SK (1) SK14512003A3 (https=)
UA (1) UA80679C2 (https=)
WO (1) WO2002102401A1 (https=)
ZA (1) ZA200305326B (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
US20020077327A1 (en) * 1999-09-23 2002-06-20 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
CN1186326C (zh) 2000-07-05 2005-01-26 山之内制药株式会社 丙－1,3－二酮衍生物
DE10137174A1 (de) * 2001-07-31 2003-02-13 Zentaris Ag Verwendung von LHRH-Antagonisten in nichtkastrierenden Dosen zur Verbesserung der T-Zellen-vermittelten Immunität
NZ552372A (en) 2004-06-04 2009-11-27 Astellas Pharma Inc Propane-1,3-dione derivative or its salt
US20080171736A1 (en) * 2004-12-23 2008-07-17 Gregory Christopher W Treatment of Alzheimer's Disease and Mild Cognitive impairment using GnRH-I analogs and one or more of acetylcholinesterase inhibitors and NMDA receptor antagonists
EP1827468B1 (en) * 2004-12-23 2012-08-22 Curaxis Pharmaceutical Corporation Acetylcholinesterase Inhibitors and leuprolide acetate for the treatment of Alzheimer's disease
SI1864976T1 (sl) * 2005-03-31 2012-12-31 Astellas Pharma Inc. Propan-1,3-dionski derivat ali njegova sol
AU2007312165A1 (en) * 2006-10-21 2008-04-24 Abbott Gmbh & Co. Kg Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors
EP2197469A2 (en) * 2007-09-11 2010-06-23 Mondobiotech Laboratories AG Use of nf-kappab inhibitor sn50 and optionally angiotensin iii as therapeutic agents in the treatment of eg hbv infection
RU2010114025A (ru) * 2007-09-11 2011-10-20 Мондобайотек Лабораториз Аг (Li) ПРИМЕНЕНИЕ ПЕПТИДА Gly-Arg-Gly-Asp-Asn-Pro В КАЧЕСТВЕ ТЕРАПЕВТИЧЕСКОГО СРЕДСТВА
EP2095818A1 (en) 2008-02-29 2009-09-02 AEterna Zentaris GmbH Use of LHRH antagonists at non-castrating doses
WO2009145690A1 (en) * 2008-05-29 2009-12-03 Isr Immune System Regulation Ab Method and means for treating viral disease, in particular hiv/aids
CA2810954A1 (en) 2010-09-27 2012-04-05 Abbott Gmbh & Co. Kg Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
US9090592B2 (en) 2010-12-30 2015-07-28 AbbVie Deutschland GmbH & Co. KG Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
EP3560555A1 (en) * 2018-04-26 2019-10-30 LifeArc A composition for treating one or more estrogen related diseases
WO2025155903A1 (en) * 2024-01-19 2025-07-24 Temple University-Of The Commonwealth System Of Higher Education Compositions of antioxidant translation modulators for treating neurodegenerative disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3135743A (en) 1960-06-29 1964-06-02 Sterling Drug Inc Steroido[2. 3-d]isoxazoles and preparation thereof
US6150352A (en) * 1996-05-20 2000-11-21 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
DE19911771B4 (de) * 1999-03-17 2006-03-30 Zentaris Gmbh LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung
CA2372044A1 (en) 1999-05-14 2000-11-23 Neurocrine Biosciences, Inc. Imidazo- and pyrrolo[1,2-a]pyrimid-4-ones as gonadotropin-releasing hormone receptor antagonists
CA2309395A1 (en) * 1999-06-04 2000-12-04 Richard Lloyd Bowen Methods for preventing and treating alzheimer's disease
DE60022769T2 (de) 1999-10-15 2006-07-06 Neurocrine Biosciences, Inc., San Diego Gonadotropin freisetzenden hormon rezeptor antagonisten und ihre verwandten verwendungen
WO2001078780A1 (en) 2000-04-13 2001-10-25 Takeda Chemical Industries, Ltd. Preventives/remedies for alzheimer's disease
CN1186326C (zh) * 2000-07-05 2005-01-26 山之内制药株式会社 丙－1,3－二酮衍生物

Also Published As

Publication number Publication date
CN1317030C (zh) 2007-05-23
DK1392348T3 (da) 2008-09-29
CZ20033167A3 (cs) 2004-08-18
ATE400287T1 (de) 2008-07-15
NZ544417A (en) 2008-03-28
MXPA03008666A (es) 2004-10-15
EP1392348B1 (en) 2008-07-09
RU2003134949A (ru) 2005-02-10
IL156777A0 (en) 2004-02-08
NO20034322L (no) 2003-09-26
EP1392348A1 (en) 2004-03-03
SI1392348T1 (sl) 2008-12-31
PL362319A1 (en) 2004-10-18
CA2444876A1 (en) 2002-12-27
BG108339A (bg) 2004-11-30
CN1575185A (zh) 2005-02-02
SK14512003A3 (sk) 2004-08-03
ES2307760T3 (es) 2008-12-01
UA80679C2 (en) 2007-10-25
US7288517B2 (en) 2007-10-30
BR0209290A (pt) 2004-07-13
AU2002310788B2 (en) 2007-04-05
US20020177556A1 (en) 2002-11-28
NO20034322D0 (no) 2003-09-26
WO2002102401A1 (en) 2002-12-27
JP2004529207A (ja) 2004-09-24
PT1392348E (pt) 2008-09-09
ZA200305326B (en) 2003-07-30
HK1072000A1 (en) 2005-08-12
KR20040000446A (ko) 2004-01-03
DE60227507D1 (de) 2008-08-21
RU2319501C2 (ru) 2008-03-20

Similar Documents

Publication Publication Date Title
HUP0400067A2 (hu) Dementia és neurodegeneratív betegségek kezelése közepes dózisú LHRH-antagonistával
IL161110A0 (en) Prevention and treatment of restenosis by local admistration of drug
GB0111872D0 (en) Therapeutic agents and methods
IL148034A0 (en) Methods of treating nuclear factor-kappa b mediated diseases and disorders
HUP0401808A3 (en) Dosage forms, devices and methods of treatment
IL161267A0 (en) Combinations for the treatment of immunoinflammatory disorders
AU2002346504A8 (en) Therapeutic protein and treatments
EP1392292A4 (en) PYRANOINDAZOLES AND THEIR USE IN GLAUCOMA TREATMENT
HUP0400005A3 (en) Use of osteopontin for the treatment and/or prevention of neurologic diseases
GB0004531D0 (en) The treatment of respiratory diseases
IL150289A0 (en) Drug combination for the treatment of depression and related disorders comprising mirtazapine
HUP0401913A3 (en) Medicine for preventing and treating bromhidrosis
EP1472273A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE DISEASES
GB0119025D0 (en) Compounds and their therapeutic use
IL153439A0 (en) Medicines for the prevention and treatment of neurodegenerative diseases
AU2002351798A1 (en) Methods and dosage forms for improving the bioavailability of therapeutic agents
DE50206175D1 (de) Thiochromenone gegen schmerzzustände und neurodegenerative erkrankungen
AU2003270540A8 (en) Treatment of cyclooxygenase-3 mediated diseases and disorders
GB2376943B (en) Compounds and their therapeutic use
AU2908501A (en) Combination therapy for the treatment of inflammatory and respiratory diseases
GB0112237D0 (en) Compounds and their therapeutic use
AU2002365654A8 (en) Treatment of diseases via the skin
GB0108892D0 (en) The treatment of respiratory diseases
AU2728301A (en) Combination therapy for the treatment of inflammatory and respiratory diseases
GB0128512D0 (en) Compounds and their therapeutic use

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: ZENTARIS GMBH, DE

Free format text: FORMER OWNER(S): ZENTARIS GMBH, DE

FD9A Lapse of provisional protection due to non-payment of fees